WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

U.S. judge blocks Colorado's first-of-its-kind price cap on an Amgen drug

A federal judge blocked a Colorado state panel from placing a cap on the price of Enbrel, a blockbuster drug sold by Amgen

Raccontata dastatnews.comendpoints.news

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
statnews.comStai leggendo2 g fa

U.S. judge blocks Colorado's first-of-its-kind price cap on an Amgen drug

A federal judge blocked a Colorado state panel from placing a cap on the price of Enbrel, a blockbuster drug sold by Amgen

originale
endpoints.news2 g fa

Court halts Colorado price cap on Amgen's blockbuster Enbrel

A federal judge blocks Colorado's 70% price cap on Amgen's Enbrel, ruling the first-in-nation limit preempted by federal patent law.

Leggi questa versione → originale

Timeline cronologica

  1. giovedì 2 luglio 2026·statnews.com

    U.S. judge blocks Colorado's first-of-its-kind price cap on an Amgen drug

    A federal judge blocked a Colorado state panel from placing a cap on the price of Enbrel, a blockbuster drug sold by Amgen

  2. giovedì 2 luglio 2026·statnews.com

    Pharmalittle: We're reading about a court win for Amgen, Novo seeking supplier discounts, and more

    U.S. judge blocked a Colorado state panel from placing a cap on the price of Amgen's blockbuster drug Enbrel

  3. giovedì 2 luglio 2026·endpoints.news

    Court halts Colorado price cap on Amgen's blockbuster Enbrel

    A federal judge blocks Colorado's 70% price cap on Amgen's Enbrel, ruling the first-in-nation limit preempted by federal patent law.